Citations

Showing 10 of 108094 citations.

Future of Metabolic Endoscopy
Ghazi, Rabih , Abboud, Donna Maria , Razak, Farah Abdul, Mahmoud, Tala , Abboud, Donna M , Vargas, Eric J. , Storm, Andrew C. , Chandrasekhara, Vinay , Dayyeh, Barham K. Abu

Mayo Clinic

Journal of Digestive Endoscopy | September 13, 2022 | Volume: 13 | Issue: 03 | Pages: 170-178

10.1055/s-0042-1754335 Get It

AbstractObesity has been escalating as one of the worst public health epidemics. Conservative therapies including lifestyle modifications and weight loss medications have limited efficacy and long-term sustainability. Bariatric surgeries, although effective, remain underutilized due to their cost, safety concerns, and patient acceptance. In the past two decades, endoscopic bariatric and metabolic therapies (EBMTs) have emerged as safe, effective, and less invasive options for the treatment of obesity and its comorbidities, with recent studies reporting favorable outcomes in terms of weight loss and metabolic parameters. This article reviews the major and newly developed EBMTs, with emphasis on their metabolic effects and potential use in the management of metabolic conditions.
Impacting Outcomes in the Hospitalized Oncology Patient: Evidence-Informed Quality and Safety Project to Implement Routine Screening for Delirium
Vonnes, Cassandra , Tofthagen, Cindy

Mayo Clinic

Patient Safety | September 13, 2022 | Volume: No volume available | Issue: No issue available | Pages: 20-29

10.33940/med/2022.9.4 Get It

Background: Delirium can occur in cancer patients during an acute hospitalization or in the terminal stages of cancer. Iatrogenic delirium can complicate hospital stays for over 2.6 million older persons by increasing fall risk, restraint use, length of stay, postacute placement, and costs. The purpose of this evidence-based quality improvement project was to implement routine screening for delirium with a consistent instrument and adopt an interprofessional plan of care for delirium. Methods: This project was identified as an interprofessional improvement initiative. The project leader identified a deficiency in the screening for delirium, convened stakeholders, evaluated evidence, reviewed screening instruments, and developed a plan of care for delirium management. Practice changes incorporated routine delirium screening across the inpatient units. A delirium interprofessional plan of care was integrated into the electronic health record for ease of adoption and workflow modification. Results: Routine screening for delirium and early interprofessional interventions reduced length of stay by 2.27 days for patients screening positive for delirium. The percentage of inpatient falls that were linked to an episode of delirium during hospitalization reduced from 23.4% to 17%. Discussions: Routine screening and targeted interventions are a first step in prevention and identification of those inpatients at risk of developing delirium. Delirium prevention is the goal for potential associated iatrogenic conditions.
Perceived influence of medical school sexual health education on specialty selection in young urologists specializing in sexual dysfunction
Aro-Lambo, Mazeed , Vencill, Jennifer A. , Collins, Charles, Köhler, Tobias , Ziegelmann, Matthew , Parikh, Niki , Collins, Charles, Helo, Sevann

Mayo Clinic

No container title available | September 13, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-1982068/v1 Get It

Abstract To determine effects of sexual health curriculum (SHC) in medical school on future urology specialty and subspecialty selection, residents, fellows, and practicing urologists completed a 15-question survey regarding their exposure to SHC during medical school, topics covered, and the influence of mentors in career choice. 95 respondents, primarily post-graduate year 4 and 5 (46%), completed the survey. Approximately 50% recalled dedicated SHC during medical school with 46% planning to pursue fellowship training in sexual medicine/reconstruction. Topics commonly covered included reproductive anatomy/physiology and sexual history-taking, while respondents rarely recalled topics such as sexual aids/toys and pornography. Only 25% felt SHC provided an adequate fund of knowledge to address patient’s sexual health concerns, and only 14% believed SHC influenced their decision to pursue urology. Individuals pursuing fellowship were more likely to have an attending mentor, a mentor with expertise in sexual dysfunction, and considered their mentor as important or very important in their decision to subspecialize (p<0.05). Most urology trainees do not have strong exposure to SHC during medical school and cite mentorship as more important in the decision to pursue subspecialty training. These data support the need for a standardized formal SHC and continued exposure to sexual health experts during training.
Effect of cx-DHED on Abnormal Glucose Transporter Expression Induced by AD Pathologies in the 5xFAD Mouse Model
Kim, Jinho , Kang, Shinwoo , Chang, Keun‐A

Mayo Clinic

International Journal of Molecular Sciences | September 13, 2022 | Volume: 23 | Issue: 18 | Pages: 10602

10.3390/ijms231810602 | PMID 36142509 Get It

Alzheimer’s disease (AD) is a form of dementia associated with abnormal glucose metabolism resulting from amyloid-beta (Aβ) plaques and intracellular neurofibrillary tau protein tangles. In a previous study, we confirmed that carboxy-dehydroevodiamine∙HCl (cx-DHED), a derivative of DHED, was effective at improving cognitive impairment and reducing phosphorylated tau levels and synaptic loss in an AD mouse model. However, the specific mechanism of action of cx-DHED is unclear. In this study, we investigated how the cx-DHED attenuates AD pathologies in the 5xFAD mouse model, focusing particularly on abnormal glucose metabolism. We analyzed behavioral changes and AD pathologies in mice after intraperitoneal injection of cx-DHED for 2 months. As expected, cx-DHED reversed memory impairment and reduced Aβ plaques and astrocyte overexpression in the brains of 5xFAD mice. Interestingly, cx-DHED reversed the abnormal expression of glucose transporters in the brains of 5xFAD mice. In addition, otherwise low O-GlcNac levels increased, and the overactivity of phosphorylated GSK-3β decreased in the brains of cx-DHED-treated 5xFAD mice. Finally, the reduction in synaptic proteins was found to also improve by treatment with cx-DHED. Therefore, we specifically demonstrated the protective effects of cx-DHED against AD pathologies and suggest that cx-DHED may be a potential therapeutic drug for AD.
A Systematic Review and Meta-Analysis Evaluating Geographical Variation in Outcomes of Cancer Patients Treated in ICUs
Nazer, Lama , López-Olivo, María A. , Brown, Anne Rain , Sirimaturos, Michael , Habash, Khader , Al‐Qadheeb, Nada S. , Milano, Victoria, Taylor, Amy , Nates, Joseph L. , May, Heather, Cuenca, John A. , May, Heather P.

Mayo Clinic

Critical Care Explorations | September 13, 2022 | Volume: 4 | Issue: 9 | Pages: e0757

10.1097/cce.0000000000000757 | PMID 36119395 Get It

OBJECTIVES: The reported mortality rates of cancer patients admitted to ICUs vary widely. In addition, there are no studies that examined the outcomes of critically ill cancer patients based on the geographical regions. Therefore, we aimed to evaluate the mortality rates among critically ill cancer patients and provide a comparison based on geography. DATA SOURCES: PubMed, EMBASE, and Web of Science. STUDY SELECTION: We included observational studies evaluating adult patients with cancer treated in ICUs. We excluded non-English studies, those with greater than 30% hematopoietic stem cell transplant or postsurgical patients, and those that evaluated a specific type of critical illness, stage of malignancy, or age group. DATA EXTRACTION: Two reviewers independently applied eligibility criteria, assessed quality, and extracted data. Studies were classified based on the continent in which they were conducted. Primary outcomes were ICU and hospital mortality. We pooled effect sizes by geographical region. DATA SYNTHESIS: Forty-six studies were included (n = 110,366). The overall quality of studies was moderate. Most of the published literature was from Europe (n = 22), followed by North America (n = 9), Asia (n = 8), South America (n = 5), and Oceania (n = 2). Pooled ICU mortality rate was 38% (95% CI, 33–43%); the lowest mortality rate was in Oceania (26%; 95% CI, 22–30%) and highest in Asia (51%; 95% CI, 44–57%). Pooled hospital mortality rate was 45% (95% CI, 41–49%), with the lowest in North America (37%; 95% CI, 31–43%) and highest in Asia (54%; 95% CI, 37–71%). CONCLUSIONS: More than half of cancer patients admitted to ICUs survived hospitalization. However, there was wide variability in the mortality rates, as well as the number of available studies among geographical regions. This variability suggests an opportunity to improve outcomes worldwide, through optimizing practice and research.
2022 ESC Guidelines on cardio-oncology: how can we improve the cardiovascular health of patients with cancer and cancer survivors?
López‐Fernández, Teresa , Herrmann, Joerg , López-Fernández, Teresa , Lyon, Alexander R.

Mayo Clinic

European Heart Journal - Cardiovascular Pharmacotherapy | September 13, 2022 | Volume: 9 | Issue: 1 | Pages: 4-5

10.1093/ehjcvp/pvac051 | PMID 36107817 Get It

How We Look At Mature Faces—An Eye-Tracking Investigation Into the Perception of Age
Frank, Konstantin , Ehrl, Denis , Bernardini, Francesco P. , Walbrun, Alina, Alfertshofer, Michael , Davidović, Kristina , Alfertshofer, Michael , Moellhoff, Nicholas , Mardini, Samir , Gotkin, Robert H. , Cotofana, Sebastian

Mayo Clinic

Aesthetic Surgery Journal | September 13, 2022 | Volume: 43 | Issue: 2 | Pages: 115-122

10.1093/asj/sjac251 | PMID 36099471 Get It

Abstract Background It is still unclear which facial region contributes most to the perception of an aged face when evaluated by eye-tracking analyses. Objectives The authors sought to apply eye-tracking technology to identify whether mature faces require longer fixation durations than young faces and which facial region contributes most to the perception of a mature face. Methods Eye-tracking analyses were conducted in 74 volunteers (37 males, 37 females; 43 ≤ 40 years, 31 &gt; 40 years) evaluating their gaze pattern and the fixation durations for the entire face and 9 facial subregions. Frontal facial images of 16 younger (&lt;40 years) and older (&gt;40 years) gender-matched individuals were presented in a standardized setting. Results Independent of age or gender of the observer, a younger stimulus image was viewed shorter than an older stimulus image with 0.82 (0.63) seconds vs 1.06 (0.73) seconds with P &lt; 0.001. There was no statistically significant difference in their duration of a stable eye fixation when observers inspected a male vs a female stimulus image [0.94 (0.70) seconds vs 0.94 (0.68) seconds; P = 0.657] independent of the observer’s age or gender. The facial image that captured the most attention of the observer (rank 9) was the perioral region with 1.61 (0.73) seconds for younger observers and 1.57 (0.73) seconds for older observers. Conclusions It was revealed that the perioral region attracts the most attention of observers and contributes most to an aged facial appearance. Practitioners should be mindful of the importance of the perioral region when designing an aesthetic treatment plan.
Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy
Tarapore, Rohinton S. , Allen, Jeffrey, McGovern, Susan L. , Zaky, Wafik , Odia, Yazmín , Daghistani, Doured , Hall, Matthew D. , Khatib, Ziad, Cantor, Evan , Kurokawa, Ryo , MacDonald, Tobey J. , Aguilera, Dolly , Vitanza, Nicholas A. , Kline, Cassie , Lu, Guangrong , Allen, Joshua E. , Khatua, Soumen , Tarapore, Rohinton S , Koschmann, Carl , Khatua, Soumen , Hall, Matthew D , Kurokawa, Ryo , Odia, Yazmin , Gardner, Sharon L , Allen, Jeffrey C. , Allen, Jeffrey, Diaz, Zuanel , Koschmann, Carl , Mueller, Sabine C.

Mayo Clinic

Neuro-Oncology Advances | September 13, 2022 | Volume: 4 | Issue: 1 | Pages: No page available

10.1093/noajnl/vdac143 | PMID 36382108 Get It

Abstract Background ONC201, a dopamine receptor D2 (DRD2) antagonist and caseinolytic protease P (ClpP) agonist, has induced durable tumor regressions in adults with recurrent H3 K27M-mutant glioma. We report results from the first phase I pediatric clinical trial of ONC201. Methods This open-label, multi-center clinical trial (NCT03416530) of ONC201 for pediatric H3 K27M-mutant diffuse midline glioma (DMG) or diffuse intrinsic pontine glioma (DIPG) employed a dose-escalation and dose-expansion design. The primary endpoint was the recommended phase II dose (RP2D). A standard 3 + 3 dose escalation design was implemented. The target dose was the previously established adult RP2D (625 mg), scaled by body weight. Twenty-two pediatric patients with DMG/DIPG were treated following radiation; prior lines of systemic therapy in addition to radiation were permitted providing sufficient time had elapsed prior to study treatment. Results The RP2D of orally administered ONC201 in this pediatric population was determined to be the adult RP2D (625 mg), scaled by body weight; no dose-limiting toxicities (DLT) occurred. The most frequent treatment-emergent Grade 1-2 AEs were headache, nausea, vomiting, dizziness and increase in alanine aminotransferase. Pharmacokinetics were determined following the first dose: T1/2, 8.4 h; Tmax, 2.1 h; Cmax, 2.3 µg/mL; AUC0-tlast, 16.4 hµg/mL. Median duration of treatment was 20.6 weeks (range 5.1-129). Five (22.7%) patients, all of whom initiated ONC201 following radiation and prior to recurrence, were alive at 2 years from diagnosis. Conclusions The adult 625 mg weekly RP2D of ONC201 scaled by body weight was well tolerated. Further investigation of ONC201 for DMG/DIPG is warranted.
Reconstruction of Triangular Fibrocartilage Complex Avulsions (Palmar 1C) with Associated Lunotriquetral and Dorsal Capsule Injury
Lenartowicz, Karina A. , Miller, Andrew , Shin, Alexander Y. , Bishop, Allen T. , Mauermann, Michelle L , Shin, Alexander Y , Bishop, Allen T , Mauermann, Michelle L.

Mayo Clinic

JBJS Case Connector | September 13, 2022 | Volume: 12 | Issue: 2 | Pages: No page available

10.2106/jbjs.cc.21.00606 | PMID 36099448 Get It

Case: A 34-year-old farmer and railroad worker injured his left wrist when working at a railroad. The resulting dorsal-ulnar wrist blow caused disabling pain. Splits and 2 subsequent surgeries failed, including an arthroscopic triangular fibrocartilage complex (TFCC) debridement and thermal ablation. Subsequently, magnetic resonance imaging documented a rare Palmer type 1C distal TFCC avulsion. Function was restored and return to farming permitted by reconstruction of the ulnotriquetral (UT) ligament using an extensor carpi ulnaris (ECU) slip. Conclusion: Chronic Palmer type 1C TFCC injuries can be successfully treated with ECU reconstruction of the UT ligament.
Homologous recombination–deficient mutation cluster in tumor suppressor RAD51C identified by comprehensive analysis of cancer variants
Prakash, Rohit , Rawal, Yashpal , Sullivan, Meghan R. , Grundy, McKenzie K. , Bret, Hélène , Mihalevic, Michael J., Rein, Hayley L. , Baird, Jared M. , Darrah, Kristie, Zhang, Fang , Modesti, Mauro , Jasin, Maria , Bernstein, Kara A. , Traina, Tiffany A , Kaufmann, Scott H , Swisher, Elizabeth M , Guérois, Raphaël , Modesti, Mauro , Jasin, Maria , Bernstein, Kara A , Sullivan, Meghan R. , Wang, Raymond , Radke, Marc R. , Kaufmann, Scott H. , Swisher, Elizabeth M. , Sung, Patrick

Mayo Clinic

Proceedings of the National Academy of Sciences | September 13, 2022 | Volume: 119 | Issue: 38 | Pages: No page available

10.1073/pnas.2202727119 | PMID 36099300 Get It

Mutations in homologous recombination (HR) genes, including BRCA1 , BRCA2 , and the RAD51 paralog RAD51C , predispose to tumorigenesis and sensitize cancers to DNA-damaging agents and poly(ADP ribose) polymerase inhibitors. However, ∼800 missense variants of unknown significance have been identified for RAD51C alone, impairing cancer risk assessment and therapeutic strategies. Here, we interrogated >50 RAD51C missense variants, finding that mutations in residues conserved with RAD51 strongly predicted HR deficiency and disrupted interactions with other RAD51 paralogs. A cluster of mutations was identified in and around the Walker A box that led to impairments in HR, interactions with three other RAD51 paralogs, binding to single-stranded DNA, and ATP hydrolysis. We generated structural models of the two RAD51 paralog complexes containing RAD51C, RAD51B-RAD51C-RAD51D-XRCC2 and RAD51C-XRCC3. Together with our functional and biochemical analyses, the structural models predict ATP binding at the interface of RAD51C interactions with other RAD51 paralogs, similar to interactions between monomers in RAD51 filaments, and explain the failure of RAD51C variants in binding multiple paralogs. Ovarian cancer patients with variants in this cluster showed exceptionally long survival, which may be relevant to the reversion potential of the variants. This comprehensive analysis provides a framework for RAD51C variant classification. Importantly, it also provides insight into the functioning of the RAD51 paralog complexes.